Cargando…

Differences in GlycA and lipoprotein particle parameters may help distinguish acute kawasaki disease from other febrile illnesses in children

BACKGROUND: Glycosylation patterns of serum proteins, such as α1-acid glycoprotein, are modified during an acute phase reaction. The response of acute Kawasaki disease (KD) patients to IVIG treatment has been linked to sialic acid levels on native IgG, suggesting that protein glycosylation patterns...

Descripción completa

Detalles Bibliográficos
Autores principales:	Connelly, Margery A., Shimizu, Chisato, Winegar, Deborah A., Shalaurova, Irina, Pourfarzib, Ray, Otvos, James D., Kanegaye, John T., Tremoulet, Adriana H., Burns, Jane C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5011873/ https://www.ncbi.nlm.nih.gov/pubmed/27596163 http://dx.doi.org/10.1186/s12887-016-0688-5

Ejemplares similares

GlycA, a novel biomarker of systemic inflammation and cardiovascular disease risk
por: Connelly, Margery A., et al.
Publicado: (2017)

A novel inflammatory biomarker, GlycA, associates with disease activity in rheumatoid arthritis and cardio-metabolic risk in BMI-matched controls
por: Bartlett, David B., et al.
Publicado: (2016)

Utility of a novel inflammatory marker, GlycA, for assessment of rheumatoid arthritis disease activity and coronary atherosclerosis
por: Ormseth, Michelle J., et al.
Publicado: (2015)

GlycA, a Pro-Inflammatory Glycoprotein Biomarker, and Incident Cardiovascular Disease: Relationship with C-Reactive Protein and Renal Function
por: Gruppen, Eke G., et al.
Publicado: (2015)

GlycA, hsCRP differentially associated with MI, ischemic stroke: In the Dallas Heart Study and Multi-Ethnic Study of Atherosclerosis: GlycA, hsCRP Differentially Associated MI, Stroke
por: Riggs, Kayla A., et al.
Publicado: (2022)

GlycA: Evaluation of a New Biomarker of Acute Pancreatitis
por: Shah, Ishani, et al.
Publicado: (2023)

Association of the Composite Inflammatory Biomarker GlycA, with Exercise-Induced Changes in Body Habitus in Men and Women with Prediabetes
por: Bartlett, David B., et al.
Publicado: (2017)

GlycA is not a useful biomarker of inflammation in sickle cell disease
por: Weisman, Julie K., et al.
Publicado: (2018)

The association of novel inflammatory marker GlycA and incident atrial fibrillation in the Multi-Ethnic Study of Atherosclerosis (MESA)
por: Jang, Sunyoung, et al.
Publicado: (2021)

Increase in the Inflammatory Marker GlycA over 13 Years in Young Adults Is Associated with Poorer Cognitive Function in Midlife
por: Cohen-Manheim, Irit, et al.
Publicado: (2015)

Towards clinical application of GlycA and GlycB for early detection of inflammation associated with (pre)diabetes and cardiovascular disease: recent evidence and updates
por: Fung, Erik, et al.
Publicado: (2023)

Urinary Colorimetric Sensor Array and Algorithm to Distinguish Kawasaki Disease from Other Febrile Illnesses
por: Li, Zhen, et al.
Publicado: (2016)

GlycA, a Biomarker of Low-Grade Inflammation, Is Increased in Male Night Shift Workers
por: Bizzarri, Daniele, et al.
Publicado: (2022)

The novel inflammatory biomarker GlycA and triglyceride-rich lipoproteins are associated with the presence of subclinical myocardial dysfunction in subjects with type 1 diabetes mellitus
por: Puig-Jové, Carlos, et al.
Publicado: (2022)

Impaired HDL Metabolism Links GlycA, A Novel Inflammatory Marker, with Incident Cardiovascular Events
por: Riggs, Kayla A., et al.
Publicado: (2019)

GlycA, a novel pro‐inflammatory glycoprotein biomarker is associated with mortality: results from the PREVEND study and meta‐analysis
por: Gruppen, E. G., et al.
Publicado: (2019)

GlycA measured by NMR spectroscopy is associated with disease activity and cardiovascular disease risk in chronic inflammatory diseases()
por: Mehta, Nehal N., et al.
Publicado: (2020)

Systemic cytokines and GlycA discriminate disease status and predict corticosteroid response in HTLV-1-associated neuroinflammation
por: Assone, Tatiane, et al.
Publicado: (2022)

GlycA, a marker of protein glycosylation, is related to albuminuria and estimated glomerular filtration rate: the ELSA-Brasil study
por: Titan, Silvia M., et al.
Publicado: (2017)

GlycA Levels during the Earliest Stages of Rheumatoid Arthritis: Potential Use as a Biomarker of Subclinical Cardiovascular Disease
por: Rodríguez-Carrio, Javier, et al.
Publicado: (2020)

Elevated serum alpha-1 antitrypsin is a major component of GlycA-associated risk for future morbidity and mortality
por: Ritchie, Scott C., et al.
Publicado: (2019)

Serum GlycA Level Is Elevated in Active Systemic Lupus Erythematosus and Correlates to Disease Activity and Lupus Nephritis Severity
por: Dierckx, Tim, et al.
Publicado: (2020)

Unbiased Screening of Kawasaki Disease Sera for Viral Antigen Exposure
por: Quiat, Daniel, et al.
Publicado: (2017)

GlycA, a Nuclear Magnetic Resonance Spectroscopy Measure for Protein Glycosylation, is a Viable Biomarker for Disease Activity in IBD
por: Dierckx, Tim, et al.
Publicado: (2019)

A diagnostic algorithm combining clinical and molecular data distinguishes Kawasaki disease from other febrile illnesses
por: Ling, Xuefeng B, et al.
Publicado: (2011)

Differential Expression of miR-145 in Children with Kawasaki Disease
por: Shimizu, Chisato, et al.
Publicado: (2013)

Association Between Smoking and Serum GlycA and High‐Sensitivity C‐Reactive Protein Levels: The Multi‐Ethnic Study of Atherosclerosis (MESA) and Brazilian Longitudinal Study of Adult Health (ELSA‐Brasil)
por: Kianoush, Sina, et al.
Publicado: (2017)

An Artificial Intelligence-guided signature reveals the shared host immune response in MIS-C and Kawasaki disease
por: Ghosh, Pradipta, et al.
Publicado: (2022)

Novel data-mining approach identifies biomarkers for diagnosis of Kawasaki disease
por: Tremoulet, Adriana H., et al.
Publicado: (2015)

Publisher Correction: An Artificial Intelligence-guided signature reveals the shared host immune response in MIS-C and Kawasaki disease
por: Ghosh, Pradipta, et al.
Publicado: (2022)

Ketone Bodies Are Mildly Elevated in Subjects with Type 2 Diabetes Mellitus and Are Inversely Associated with Insulin Resistance as Measured by the Lipoprotein Insulin Resistance Index
por: Garcia, Erwin, et al.
Publicado: (2020)

A Dietitian-Led Vegan Program May Improve GlycA, and Other Novel and Traditional Cardiometabolic Risk Factors in Patients With Dyslipidemia: A Pilot Study
por: Chiu, Tina H. T., et al.
Publicado: (2022)

Treatment Response in Kawasaki Disease Is Associated with Sialylation Levels of Endogenous but Not Therapeutic Intravenous Immunoglobulin G
por: Ogata, Shohei, et al.
Publicado: (2013)

GlycA, a novel marker for low grade inflammation, reflects gut microbiome diversity and is more accurate than high sensitive CRP in reflecting metabolomic profile
por: Mokkala, Kati, et al.
Publicado: (2020)

High-throughput nuclear magnetic resonance measurement of citrate in serum and plasma in the clinical laboratory
por: Garcia, Erwin, et al.
Publicado: (2021)

Biomarkers of Inflammation and Fibrosis in Kawasaki Disease Patients Years After Initial Presentation With Low Ejection Fraction
por: Hoshino, Shinsuke, et al.
Publicado: (2019)

DOACs in Patients With Giant Coronary Artery Aneurysms After Kawasaki Disease
por: Dummer, Kirsten B., et al.
Publicado: (2023)

A Newly Developed Diabetes Risk Index, Based on Lipoprotein Subfractions and Branched Chain Amino Acids, is Associated with Incident Type 2 Diabetes Mellitus in the PREVEND Cohort
por: Flores-Guerrero, Jose L., et al.
Publicado: (2020)

Association Between Smoking and Serum GlycA and High‐Sensitivity C‐Reactive Protein Levels: The Multi‐Ethnic Study of Atherosclerosis (MESA) and Brazilian Longitudinal Study of Adult Health (ELSA‐Brasil)
Publicado: (2017)

Gene-expression patterns reveal underlying biological processes in Kawasaki disease
por: Popper, Stephen J, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_ovibr20mfsvvp60eo95f24cnpq